Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the page is currently inaccessible.SummaryDifference0.5%

- Check15 days agoChange DetectedAccessing the study record now results in a 403 Forbidden error page, indicating restricted access. The rest of the site chrome remains, but the study content is not viewable.SummaryDifference20%

- Check36 days agoChange DetectedThe page's revision label changed from v3.6.5 to v3.6.6, signaling a minor update to the study record’s documentation or formatting. This appears to be a backend/editorial update rather than changes to study data or eligibility information.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded the Study Protocol and Statistical Analysis Plan (PDF) to the Study Documents section, along with related metadata and MeSH terms. This expands the published documentation of the trial's design and planned analyses.SummaryDifference66%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a new version of the page. This appears to be a metadata-level update rather than a substantive change to the study data.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the study record. This likely reflects internal QA or small edits without changing the study details.SummaryDifference0.0%

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.